Stay updated on Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0. No study content or core page functionality appears to be altered.
    Difference
    0.1%
    Check dated 2026-03-19T09:59:49.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page shows an updated revision: v3.4.3 replaces the previous v3.4.2. This is a backend/versioning update and does not alter clinical trial details presented.
    Difference
    0.1%
    Check dated 2026-03-12T04:42:53.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 and the prior government-funding status notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:55:05.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A site-wide funding notice regarding government funding and operations was added, and the site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:49:19.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option. Updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updated the revision to 'Revision: v3.4.0' (from 'Revision: v3.3.4').
    Difference
    0.2%
    Check dated 2026-01-28T06:16:59.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 with no changes to study details, eligibility criteria, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:30:33.000Z thumbnail image

Stay in the know with updates to Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.